Multiple mutations within individual oncogenes.

Area of Science:

• Cancer Genomics
• Oncology
• Molecular Biology

Background:

• Cancer genomes reveal multiple mutations (MM) within single oncogenes in many patients.
• These mutations, particularly de novo MM, can synergistically activate oncogenes, promoting tumorigenesis via positive epistasis.

Purpose of the Study:

• To compare de novo MM and secondary MM, analyzing their similarities and differences.
• To explore the role of different MM types in cancer evolution and therapeutic response.
• To investigate the mechanisms of mutation selection in de novo MM.

Main Methods:

• Comparative analysis of de novo MM and secondary MM.
• Examination of allelic configuration, mutational selection, and individual mutation functionality.
• Assessment of drug sensitivities and biomarker potential.

Main Results:

• De novo MM and secondary MM share similarities in configuration and selection but differ in drug sensitivity.
• De novo MM can increase sensitivity to targeted therapies, while secondary MM often confer resistance.
• Minor, weak mutations are convergently selected in de novo MM, explaining their accumulation.

Conclusions:

• Multiple mutations within oncogenes are diverse, encompassing de novo, secondary, and subclone-derived types.
• All MM types are linked to cancer evolution and influence therapeutic outcomes.
• Further research into oncogenic MM is crucial for understanding cancer genetics and developing treatments.